Table of Contents
Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Cryotherapy Market Variables, Trends, And Scope
3.1 Penetration And Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising Prevalence Of Cancer And Other Chronic Diseases
3.2.1.2 Increasing Adoption Of Minimally Invasive Procedures
3.2.1.3 Growing Geriatric Population
3.2.2 Market Restraint Analysis
3.2.2.1 Adverse Effects Associated With Cryotherapy
3.2.2.2 Limitations Of Cryotherapy
3.3 Industry Analysis – Porter’s
3.4 PESTEL Analysis
3.5 Trend Analysis
3.6 Supply Demand Analysis
3.7 Regulatory Framework
Chapter 4 Cryotherapy Market: Segment Analysis, By Therapy Type, 2018 – 2028 (USD Million)
4.1 Cryotherapy Market: Therapy Type Movement Analysis
4.2 Cryosurgery
4.2.1 Cryosurgery Market, 2018 – 2030 (USD Million)
4.3 Icepack Therapy
4.3.1 Icepack Therapy Market, 2018 – 2030 (USD Million)
4.4 Chamber Therapy
4.4.1 Chamber Therapy Market, 2018 – 2030 (USD Million)
Chapter 5 Cryotherapy Market: Segment Analysis, By Device Type, 2018 – 2030 (USD Million)
5.1 Cryotherapy Market: Device Type Movement Analysis
5.2 Cryogun
5.2.1 Cryogun Market, 2018 – 2030 (USD Million)
5.3 Cryoprobes
5.3.1 Cryoprobes Market, 2018 – 2030 (USD Million)
5.4 Gas Cylinders
5.4.1 Gas Cylinders Market, 2018 – 2030 (USD Million)
5.5 Localized Cryotherapy Devices
5.5.1 Localized Cryotherapy Devices Market, 2018 – 2030 (USD Million)
5.6 Cryochambers And Cryosaunas
5.6.1 Cryochambers & Cryosaunas Market, 2018 – 2030 (USD Million)
5.7 Others
5.7.1 Others Market, 2018 – 2030 (USD Million)
Chapter 6 Cryotherapy Market: Segment Analysis, By Application, 2018 – 2030 (USD Million)
6.1 Cryotherapy Market: Application Movement Analysis
6.2 Surgical Applications
6.2.1 Oncology Market, 2018 – 2030 (USD Million)
6.2.2 Cardiology Market, 2018 – 2030 (USD Million)
6.2.3 Dermatology Market, 2018 – 2030 (USD Million)
6.2.4 Ophthalmology Market, 2018 – 2030 (USD Million)
6.2.5 Gynecology Market, 2018 – 2030 (USD Million)
6.3 Pain Management
6.3.1 Pain Management Market, 2018 – 2030 (USD Million)
6.4 Beauty And Wellness
6.4.1 Beauty And Wellness Market, 2018 – 2030 (USD Million)
6.5 Fitness
6.5.1 Fitness Market, 2018 – 2030 (USD Million)
6.6 Cold Storage
6.6.1 Cold Storage Market, 2018 – 2030 (USD Million)
6.7 Others
6.7.1 Others Market, 2018 – 2030 (USD Million)
Chapter 7 Cryotherapy Market: Segment Analysis, By End Use, 2018 – 2030 (USD Million)
7.1 Cryotherapy Market: End-Use Movement Analysis
7.2 Hospitals And Specialty Clinics
7.2.1 Hospitals And Specialty Clinics Market, 2018 – 2030 (USD Million)
7.3 Cryotherapy Centers
7.3.1 Cryotherapy Centers Market, 2018 – 2030 (USD Million)
7.4 Spas And Fitness Centers
7.4.1 Spas And Fitness Centers Market, 2018 – 2030 (USD Million)
7.5 Others
7.5.1 Others Market, 2018 – 2030 (USD Million)
Chapter 8 Cryotherapy Market: Segment Analysis, By Region, 2018 – 2030 (USD Million)
8.1 Cryotherapy Market: Regional Outlook
8.2 North America
8.2.1 North America Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.2.2.3 Target Disease Prevalence
8.2.2.5 Competitive Scenario
8.2.2.6 Regulatory Framework
8.2.2.7 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Canada Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.2.3.3 Target Disease Prevalence
8.2.3.4 Competitive Scenario
8.2.3.5 Regulatory Framework
8.2.3.6 Reimbursement Scenario
8.3 Europe
8.3.1 Europe Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.2 The Netherlands
8.3.2.1 Key Country Dynamics
8.3.2.2 The Netherlands Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.2.3 Target Disease Prevalence
8.3.2.4 Competitive Scenario
8.3.2.5 Regulatory Framework
8.3.2.6 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.3.3 Target Disease Prevalence
8.3.3.4 Competitive Scenario
8.3.3.5 Regulatory Framework
8.3.3.6 Reimbursement Scenario
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.4.3 Target Disease Prevalence
8.3.4.4 Competitive Scenario
8.3.4.5 Regulatory Framework
8.3.4.6 Reimbursement Scenario
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Italy Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.5.3 Target Disease Prevalence
8.3.5.4 Competitive Scenario
8.3.5.5 Regulatory Framework
8.3.5.6 Reimbursement Scenario
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Spain Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.6.3 Target Disease Prevalence
8.3.6.4 Competitive Scenario
8.3.6.5 Regulatory Framework
8.3.6.6 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.7.3 Target Disease Prevalence
8.3.7.4 Competitive Scenario
8.3.7.5 Regulatory Framework
8.3.7.6 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.8.3 Target Disease Prevalence
8.3.8.4 Competitive Scenario
8.3.8.5 Regulatory Framework
8.3.8.6 Reimbursement Scenario
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.9.3 Target Disease Prevalence
8.3.9.4 Competitive Scenario
8.3.9.5 Regulatory Framework
8.3.9.6 Reimbursement Scenario
8.3.10 Poland
8.3.10.1 Key Country Dynamics
8.3.10.2 Poland Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.10.3 Target Disease Prevalence
8.3.10.4 Competitive Scenario
8.3.10.5 Regulatory Framework
8.3.10.6 Reimbursement Scenario
8.3.11 Austria
8.3.11.1 Key Country Dynamics
8.3.11.2 Austria Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.11.3 Target Disease Prevalence
8.3.11.4 Competitive Scenario
8.3.11.5 Regulatory Framework
8.3.11.6 Reimbursement Scenario
8.3.12 Switzerland
8.3.12.1 Key Country Dynamics
8.3.12.2 Switzerland Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.12.3 Target Disease Prevalence
8.3.12.4 Competitive Scenario
8.3.12.5 Regulatory Framework
8.3.12.6 Reimbursement Scenario
8.3.13 Slovakia
8.3.13.1 Key Country Dynamics
8.3.13.2 Slovakia Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.3.13.3 Target Disease Prevalence
8.3.13.4 Competitive Scenario
8.3.13.5 Regulatory Framework
8.3.13.6 Reimbursement Scenario
8.4 Asia Pacific
8.4.1 Asia Pacific Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.2.3 Target Disease Prevalence
8.4.2.4 Competitive Scenario
8.4.2.5 Regulatory Framework
8.4.2.6 Reimbursement Scenario
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.3.3 Target Disease Prevalence
8.4.3.4 Competitive Scenario
8.4.3.5 Regulatory Framework
8.4.3.6 Reimbursement Scenario
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.4.3 Target Disease Prevalence
8.4.4.4 Competitive Scenario
8.4.4.5 Regulatory Framework
8.4.4.6 Reimbursement Scenario
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.5.3 Target Disease Prevalence
8.4.5.4 Competitive Scenario
8.4.5.5 Regulatory Framework
8.4.5.6 Reimbursement Scenario
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 South Korea Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.6.3 Target Disease Prevalence
8.4.6.4 Competitive Scenario
8.4.6.5 Regulatory Framework
8.4.6.6 Reimbursement Scenario
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Thailand Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.7.3 Target Disease Prevalence
8.4.7.4 Competitive Scenario
8.4.7.5 Regulatory Framework
8.4.7.6 Reimbursement Scenario
8.4.8 South Korea
8.4.8.1 Key Country Dynamics
8.4.8.2 South Korea Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.8.3 Target Disease Prevalence
8.4.8.4 Competitive Scenario
8.4.8.5 Regulatory Framework
8.4.8.6 Reimbursement Scenario
8.4.9 Australia
8.4.9.1 Key Country Dynamics
8.4.9.2 Australia Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.4.9.3 Target Disease Prevalence
8.4.9.4 Competitive Scenario
8.4.9.5 Regulatory Framework
8.4.9.6 Reimbursement Scenario
8.5 Latin America
8.5.1 Latin America Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.5.2.3 Target Disease Prevalence
8.5.2.4 Competitive Scenario
8.5.2.5 Regulatory Framework
8.5.2.6 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.5.3.3 Target Disease Prevalence
8.5.3.4 Competitive Scenario
8.5.3.5 Regulatory Framework
8.5.3.6 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.5.4.3 Target Disease Prevalence
8.5.4.4 Competitive Scenario
8.5.4.5 Regulatory Framework
8.5.4.6 Reimbursement Scenario
8.6 Middle East And Africa
8.6.1 Middle East And Africa Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.1.1 Target Disease Prevalence
8.6.1.2 Competitive Scenario
8.6.1.3 Regulatory Framework
8.6.1.4 Reimbursement Scenario
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 South Africa Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.2.3 Target Disease Prevalence
8.6.2.4 Competitive Scenario
8.6.2.5 Regulatory Framework
8.6.2.6 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Saudi Arabia Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.3.3 Target Disease Prevalence
8.6.3.4 Competitive Scenario
8.6.3.5 Regulatory Framework
8.6.3.6 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 UAE Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.4.3 Target Disease Prevalence
8.6.4.4 Competitive Scenario
8.6.4.5 Regulatory Framework
8.6.4.6 Reimbursement Scenario
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Kuwait Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.5.3 Target Disease Prevalence
8.6.5.4 Competitive Scenario
8.6.5.5 Regulatory Framework
8.6.5.6 Reimbursement Scenario
8.6.6 Turkey
8.6.6.1 Key Country Dynamics
8.6.6.2 Turkey Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.6.3 Target Disease Prevalence
8.6.6.4 Competitive Scenario
8.6.6.5 Regulatory Framework
8.6.6.6 Reimbursement Scenario
8.6.7 Egypt
8.6.7.1 Key Country Dynamics
8.6.7.2 Egypt Cryotherapy Market Estimates & Forecasts, 2018 – 2030 (USD Million)
8.6.7.3 Target Disease Prevalence
8.6.7.4 Competitive Scenario
8.6.7.5 Regulatory Framework
8.6.7.6 Reimbursement Scenario
Chapter 9 Cryotherapy Market: Competitive Analysis
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4 Collaboration
9.2.5 Funding
9.3 Key Company Market Share Analysis, 2022
9.4 Company Profiles
9.4.1 Brymill Cryogenic Systems
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Metrum Cryoflex
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Medtronic
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Cortex Technology
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 Mectronic Medicale S.r.l.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 ERBE Elektromedizin GmbH
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Special Medical Technology Co., Ltd.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 Boston Scientific Corporation
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 Physiomed Elektromedizin AG
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 Zimmer MedizinSysteme GmbH
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
9.4.11 Kaya Skin Clinic
9.4.11.1 Company Overview
9.4.11.2 Financial Performance
9.4.11.3 Product Benchmarking
9.4.11.4 Strategic Initiatives
9.4.12 Silkor
9.4.12.1 Company Overview
9.4.12.2 Financial Performance
9.4.12.3 Product Benchmarking
9.4.12.4 Strategic Initiatives
9.4.13 Novique Medical Aesthetics
9.4.13.1 Company Overview
9.4.13.2 Financial Performance
9.4.13.3 Product Benchmarking
9.4.13.4 Strategic Initiatives
9.4.14 LondonCryo Limited
9.4.14.1 Company Overview
9.4.14.2 Financial Performance
9.4.14.3 Product Benchmarking
9.4.14.4 Strategic Initiatives
9.4.15 Cryo
9.4.15.1 Company Overview
9.4.15.2 Financial Performance
9.4.15.3 Product Benchmarking
9.4.15.4 Strategic Initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer